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Abstract
Conditional gene deletion in specific cell populations has helped the understanding of pancreas development. Using this
approach, we have shown that deleting the glucocorticoid receptor (GR) gene in pancreatic precursor cells leads to a
doubled beta-cell mass. Here, we provide genetic tools that permit a temporally and spatially controlled expression of
target genes in pancreatic cells using the Tetracycline inducible system. To efficiently target the Tetracycline transactivator
(tTA) in specific cell populations, we generated Bacterial Artificial Chromosomes (BAC) transgenic mice expressing the
improved Tetracycline transactivator (itTA) either in pancreatic progenitor cells expressing the transcription factor Pdx1
(BAC-Pdx1-itTA), or in beta cells expressing the insulin1 gene (BAC-Ins1-itTA). In the two transgenic models, itTA-mediated
activation of reporter genes was efficient and subject to regulation by Doxycycline (Dox). The analysis of a tetracycline-
regulated LacZ reporter gene shows that in BAC-Pdx1-itTA mice, itTA is expressed from embryonic (E) day 11.5 in all
pancreatic precursor cells. In the adult pancreas, itTA is active in mature beta, delta cells and in few acinar cells. In BAC-Ins1-
itTA mice tTA is active from E13.5 and is restricted to beta cells in fetal and adult pancreas. In both lines, tTA activity was
suppressed by Dox treatment and re-induced after Dox removal. Using these transgenic lines, we overexpressed the GR in
selective pancreatic cell populations and found that overexpression in precursor cells altered adult beta-cell fraction but not
glucose tolerance. In contrast, GR overexpression in mature beta cells did not alter beta-cell fraction but impaired glucose
tolerance with insufficient insulin secretion. In conclusion, these new itTA mouse models will allow fine-tuning of gene
expression to investigate gene function in pancreatic biology and help us understand how glucocorticoid signaling affects
on the long-term distinct aspects of beta-cell biology.
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Introduction
The pancreas is a complex organ composed of both exocrine
and endocrine cells. The exocrine cells make up the majority of the
pancreas and are grouped together into a highly branched ductal
system that produce and secrete enzymes into the digestive tract.
The endocrine portion is composed of four major cell types, alpha,
beta, delta and pancreatic polypeptide (PP) cells that secrete into
the bloodstream glucagon, insulin, somatostatin and PP respec-
tively. The endocrine cells that account for approximately 1% of
the volume of the pancreas are grouped as clusters of cells named
islets of Langerhans, which are dispersed in the exocrine tissue (for
review see [1]).
All pancreatic cells arise from common precursors present at an
early stage of embryonic development. The differentiation of these
precursors into mature cells requires controlled expression of
transcription factors as well as factors produced both by the
pancreas and the surrounding tissues [2].
In recent years, great knowledge about genes that regulate
pancreatic development and beta-cell function has been gathered,
mostly thanks to the use of transgenic mice allowing Cre-mediated
DNA recombination in specific pancreatic cell populations. Using
this approach, we have shown that deletion of the glucocorticoid
receptor (GR) gene in beta cells (using RipCre mice) had no effect
on beta-cell mass whereas GR gene deletion in pancreatic
precursors (using PdxCre mice) led to a doubled beta-cell mass
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clearly defined glucocorticoids as major inhibitors of beta-cell
development. More recently, we provided genetic evidence that
the GR was required for the deleterious effects of fetal
undernutrition on beta-cell development [5]. Altogether, these
results highlight the importance of generating and using mouse
models that allow for gene modifications not only in specific cell
populations but also during specific time frames.
The tetracycline-dependent regulatory (tet) system allows a
precise spatial and temporal control of transgene expression [6]. In
the present study, we applied this approach to pancreatic cells.
The tet system relies on two components: a transgene that allows
the expression of the tetracycline-controlled transactivator (tTA)
and a transgene that contains a gene of interest under the control
of a synthetic tTA-dependent promoter (tetO). In the absence of
tetracycline or analog molecules (such as Doxycycline or Dox),
tTA binds to the tetO DNA sequences, allowing activation of the
tTA-dependent promoter and transcription of the gene of interest.
In the presence of Dox, tTA undergoes a conformational switch
and cannot interact with its DNA target and transcription of the
gene of interest does not occur. This system provides several
advantages: it combines the possibility of expressing a gene in a
cell-specific manner and stopping its expression by Dox admin-
istration.
We generated two novel transgenic mouse lines expressing an
improved version of the tTA, the itTA gene [7]. Since the most
efficient approach to express a transgene is to use large DNA
segments, we placed the itTA coding sequence under the control
of the regulatory elements of either the Pdx1 or the Insulin1 genes
using bacterial artificial chromosomes (BAC) spanning the entire
genomic regions of Pdx1 or Insulin1 genes. We show that in these
mice, itTA mediates the activation of a reporter gene specifically in
Pdx1- or Insulin1-expressing cells. We also show that its activity can
be regulated by Dox administration thus allowing the reversible
expression of targeted genes. We then examined the consequences
of conditional GR overexpression in a specific pancreatic cell
populations. Our results demonstrate that these mouse lines will be
exquisite tools for the development of mouse models to study how
specific genes modulate pancreas development and function.
Materials and Methods
Mouse husbandry
Animals were bred and raised under standard animal housing
conditions, in a 12-h light/dark cycle (7am–7pm), temperature
(2261uC) and humidity (6065%). Food and water were available
ad libitum. All experiments were performed in accordance with
French (Ministe `re de l’Agriculture et de la Fore ˆt, 87-848) and
European Economic Community (EEC, 86-6091) guidelines for
care of laboratory animals. The experiments were examined and
approved by the Regional Ethics Committee in Animal Experi-
ment Nu3 of Ile-de-France region (reference p3/2008/012).
Generation of transgenic mice
Pdx1-itTA Mice. Using the Ensembl genome database, we
chose a 196 kb mouse BAC RP24-367D23 containing the Pdx1
gene from C57BL/6J BAC library. The corresponding clone was
obtained from CHORI-USA (http://www.chori.org) and was
modified by subsequent homologous recombination steps in
EL250 bacteria according to Lee et al. [8]. This clone contains
two other genes, Cdx2 and Flt3. In order to avoid any gene dosage
effects due to the presence of extra copies, these two genes in the
transgenic mice were inactivated. The Cdx2 first exon including
the ATG initiation site was initially replaced by an ampicillin
resistance gene flanked with two modified FRT (Flippase
Recognition Target) DNA sequences (FRT3) that cannot
recombine with classical FRT sites [9]. The homologous
recombination cassette was amplified by PCR from the plasmid
‘‘pIntron-polyA FRT3-NotI-Amp- FRT3’’ (kindly provided by Dr.
E. Casanova) using the following primers: Cdx2 59 homology arm:
59AGCTACCTTCTGGACAAGGACGTGAGCATTTATCCTAGC-
TCCGTGCGCCAAAGAACCAGCTGGGGCTCGA39, Cdx2 39
homology arm:
59CTTCCTAGGGACTGCTGCGCGGGCTTCCGAATCCACTCGC-
ACAGGTTTCGGAATGCAGCTAGCCGTTAAT 39. Each prim-
er consists of 20 base homologues to the ampicillin DNA sequence
and 50 bases corresponding to the Cdx2 gene homology arms (in
italics). The amplified targeting cassette thus contained the
ampicillin gene coding sequence flanked by two FRT3 and two
Cdx2 gene homology arms located upstream and downstream of
the ampicillin-FRT3 DNA sequence.
The recombination was performed as previously described [8].
Briefly, EL250 bacteria were transformed with 500 ng BAC DNA
by electroporation. Subsequently, the BAC-containing EL250
bacteria were incubated 15 min at 42uC to induce recombination
enzymes and transformed with 400 ng of the targeting cassette.
Transformants were selected on ampicillin (100 mg/ml) and
chloramphenicol (12.5 mg/ml) plates. Correctly targeted colonies
were identified by restriction site analysis. Flippase expression from
EL250 cells was then induced by incubating the cultures with
0.1% L-arabinose for 1 h allowing the excision of the ampicillin
gene. The bacteria were plated on ampicillin to test for the loss of
ampicillin resistance. The BAC was purified an analyzed for
adequate modification. The resulting BAC was submitted to a
second homologous recombination step to introduce the itTA
coding sequence (gift of Rolf Sprengel, MPI Heidelberg) into the
BAC at the Pdx1 ATG initiation site and until 188 nucleotides (nt)
after thus disrupting the Pdx1 Open Reading Frame (ORF). To
create the targeting cassette, Pdx1 homology arms were generated
and subcloned into a pRK5-itTA plasmid containing the itTA
coding sequence, and a polyA transcriptional termination signals,
followed by the ampicillin gene flanked by two FRT sites in the
same orientation. The 59 homology sequences of 200-bp was
amplified by PCR (primer-F 59GCGGGGTACCGGCCAAT-
GATGGCTCCAGGG, primer-R: 59-AACCATCGATTGG-
GGGCCAGCAGCCCCGGG), digested with Kpn1 and Cla1
and cloned into the corresponding sites upstream of the ATG
codon of the itTA gene. Similarly, a 200-bp DNA segment located
within the Pdx1 ORF was amplified by PCR (primer-F:
59ATAGGCTAGC CATCTCCCCATACGAAGTGC, primer-
R: 59- GCATGTATACTGGTGGATTTCAGCCACGGG), di-
gested with Nhe1 and BstZ1, and subcloned downstream of the
ampicillin sequence. The targeting cassette was introduced into the
BAC by homologous recombination as described above. Correctly
recombined BAC clones were identified by DNA restriction
analysis and pulsed-field gel electrophoresis.
After removal of the ampicillin selection cassette, BAC DNA
was digested with BsiW1 resulting in the inactivation of Flt3 gene
and excision of a 165 kb long DNA fragment. This fragment was
then purified on Sepharose CL4b (Pharmacia) chromatography
columns and used for pronuclear injections into C57BL/6J zygotes
performed at the Service des Animaux Transge ´niques (SEAT,
Villejuif, France) of the Centre National de la Recherche
Scientifique.
The BAC-Pdx1-itTA transgenic line has been deposited at the
European Mouse Mutant Archives (http://www. emma ).
Ins1-itTA mice. A mouse BAC RP23-401C13 clone
containing the Insulin1 gene from C57BL/6J BAC library was
New Inducible Transgenic Mice for Pancreas Biology
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net.orgchosen using Ensembl genome database and obtained from
CHORI-USA. The BAC clone was modified as described above
to introduce at the ATG of the gene a cassette positioning the
ATG of the itTA gene followed by an ampicillin resistance gene,
flanked by two FRT sites. To create the targeting cassette, Insulin1
59 and 39 homology arms were generated and subcloned into
pRK5-itTA plasmid containing itTA coding sequence followed by
the ampicillin gene flanked by two FRT sites in the same
orientation. The polyA-transcriptional termination signal
sequence initially present in the plasmid was removed by
BamH1 and Xho1 digestion. The Insulin1 59 homology sequence
of 200-bp was amplified by PCR (primer-F: 59CGG-
GGGTACCACTATAAAGCTGGTGGGCAT, primer-R: 59G-
CCCATCGATGAAAGATAGGCAGGGTTGAG), digested with
Kpn1 and Cla1 and cloned into the corresponding sites upstream
of the ATG codon of the itTA gene. Similarly, a 200-bp DNA
segment located within the Insulin1 ORF was amplified by PCR
(primer-F: 59ATAGGCTAGCGCTTCTTCTACACACCCAA,
primer-R: 59GACTGTATACTAGTTCTCCAGCTGGTAGAG),
digested with Nhe1 and BstZ1 and subcloned downstream of
the ampicillin sequence. The targeting cassette was excised by
Kpn1 and BstZ1 digestion, and inserted by homologous
recombination into the BAC, replacing a fragment beginning
3 nucleotides before the Insulin1 ATG and ending 314 nt after.
This resulted in the substitution of the Insulin1 gene ORF by the
itTA gene. The restriction pattern of the BAC DNA was
checked by pulsed-field gel electrophoresis before and after each
modification step. The 190-kb insert was excised by Not1
digestion and purified on Sepharose CL4b (Pharmacia)
chromatography columns before injection into DBA/FVBN
zygotes performed at the Service des Animaux Transge ´niques
(SEAT, Villejuif, France) of the Centre National de la
Recherche Scientifique.
The BAC-Ins1itTA transgenic line has been deposited in the
European Mouse Mutant Archives
Generation of double transgenic mice
Tg(BAC-Pdx1-itTA);Tg(LacZtetOhGR) and Tg(BAC-Ins1-it-
TA);Tg(LacZtetOhGR) double transgenic mice were obtained
by crossing transgenic mice from the Pdx1-itTA or Ins1-itTA lines
with mice bearing a transgene that contains the lacZ and the
human GR genes under the control of the tetracycline response
element, the LacZtetOhGR mice that were previously described
[10]. Transgenic animals were identified by PCR amplification of
genomic DNA prepared from tail biopsy using the following
primers: For Pdx1-itTA: forward primer GCGGGGTACCGGC-
CAATGATGGCTCCAGGG and reverse primer GTCC-
TGCCAGGACTCCCCTTCCAGAGGGCA. For Ins1-itTA:
forward primer CGGGGGTACCACTATAAAGCTGGTGGG-
CAT and same reverse primer than for Pdx1-itTA. For the
presence of LacZtetOhGR we used the following primers: forward
primer GTCGTTTTACAACGTCGTGACT and reverse primer
GATGGGCGCATCGTAACCGTGC.
Analysis of LacZ expression
Pancreata were collected from adult male mice. For early
embryonic stages (embryonic days E11.5 or E13.5), analysis of
beta-galactosidase expression, encoded by the LacZ gene, was
performed on digestive blocks. Briefly, fetal tissues were excised,
fixed for one hour in 4% paraformaldehyde, and incubated
overnight in 40 mg/ml Xgal (Sigma) solution as previously
described [11]. For postnatal pancreata, organs were dissected,
fixed for 1 h in 4% paraformaldehyde, cryoprotected overnight in
30% sucrose, frozen and 10 mm-frozen sections were prepared.
Xgal (40 mg/ml) staining was performed on sections that were
subsequently counterstained with 1% eosin solution and mounted
with Glycergel (Dako).
Immunofluorescence
For localization of Xgal staining on adult pancreatic sections,
Xgal staining was performed as described above and sections were
subsequently incubated overnight with antibodies raised against
insulin (Dako), glucagon (Sigma), Somatostatin (Sigma), PP
(Sigma) or amylase (Sigma). Sections were then incubated for
1 h with appropriate secondary antibodies coupled to fluorescein
or Texas Red (Jackson Immunoresearch). Pictures were taken on a
DMRB fluorescent microscope with a DFX350 digital camera
(Leica).
Immunohistochemistry
Staining for the GR was performed on pancreatic sections from
Pdx1-itTA/ LacZtetOhGR, Ins1-itTA/LacZtetOhGR and con-
trol (LacZtetOhGR) mice with an anti-GR antibody M20 (Santa
Cruz Biotechnologies). Secondary antibody coupled to horseradish
peroxidase (Jackson Immunoresearch) was used and revealed with
DAB+ (Dako).
Treatment with doxycycline
Control of itTA activity and lacZ expression was achieved by
giving Dox to mice in the drinking water at 0.1 mg/ml when given
to pregnant females or at 1 mg/ml when given to other adult
mice.
Beta-cell mass and glucose homeostasis in double
mutant GR overexpressing mice
These experiments were performed in male adult mice. Beta-
cell fraction and mass were assessed as previously described [5].
Briefly, pancreata from male animals were dissected, fixed in
formalin, embedded in paraffin and entirely sectioned at a
thickness of 5 mm. Eight sections taken at regular intervals
throughout the whole pancreas were then stained for insulin.
Beta-cell fraction was defined as the ratio of the insulin staining to
the whole tissue area, both parameters analyzed on a Leica
QWin500 system. Beta-cell mass was obtained by multiplying the
beta-cell fraction by the pancreatic weight. To assess glucose
homeostasis, intra-peritoneal glucose tolerance tests were per-
formed on overnight-fasted mice by injecting glucose at 2 g/kg
body weight and measuring blood glucose levels before and 15, 30,
60 and 120 minutes after glucose injection. Serum insulin
concentrations were measured by ELISA (Mercodia).
Statistical analysis
Results are expressed as means 6 SD. The statistical
significance of variations was tested by a Mann-Whitney non-
parametric test. p values,0.05 were considered significant.
Results
Generation and characterization of Pdx1-itTA transgenic
mice
The tTA system requires two independent lines of transgenic
mice: one line expresses the tTA under the control of a specific
promoter, and a second line carries a tTA-responsive tetO
promoter linked to the target gene of interest. When the two
transgenes are present in the same mouse, the tetO-controlled
gene is activated only in the cells expressing the tTA. The
expression of the target gene can be suppressed by doxycycline.
New Inducible Transgenic Mice for Pancreas Biology
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e30210We used a transgene based on a modified Bacterial Artificial
Chromosome (BAC) clones to direct the expression of improved
tetracycline-controlled transactivator (itTA) [7], specifically in
Pdx1- or Insulin1- expressing cells. Such a strategy has proved to be
more efficient than classical constructs to target a correct
expression of the transgene [11,12,13].
Using the Ensembl genome database, we chose two BAC clones
(RP24-367D23) and (RP23-401C13) encompassing the entire
mouse Pdx1 or Insulin1 gene respectively. The Pdx1 clone contained
78 kb of DNA sequence upstream from the Pdx1 gene start codon
and 118 kb of DNA downstream of the polyadenylation signals
sequence of the gene (Fig. 1A). The clone contains also the caudal-
related homeobox 2 gene (Cdx2) and the FMS-like tyrosine kinase-3 (Flt3)
gene. To avoid any gene dosage effects and considering that Cdx2 is
expressed in the developing intestine [14] and could eventually
interfere with pancreatic development, both genes were inactivated
in the BAC. The BAC was further modified to substitute, from the
ATG, the Pdx1 gene with the itTA ORF. We chose the itTA gene
thatencodesthesameproteinthantTAbutwithanimprovedcodon
usage [7]. These transgenic mice were named Tg:BAC-Pdx1-itTA
and will be referred in the manuscript as Pdx1-itTA mice.
A target transgene, which carries a bidirectional TetO promoter
controlling the simultaneous expression of the LacZ and the
human GR (hGR) genes, was previously developed [10] (Fig. 1)
and has been used here to characterize itTA activity. Double
transgenic mice were obtained by crossing either the Pdx1-itTA or
the Ins1-itTA lines with the LacZtetOhGR line carrying the
bidirectional tetO promoter [10].
Figure 1. Generation and characterization of mice expressing the itTA under the control of Pdx1 regulatory elements. (A) Bacterial
Artificial Chromosomes (BAC) containing 202 kb of the genomic region of Pdx1 was obtained from a BAC library developed by the CHORI, Oakland,
USA. The coding region of the gene was removed by homologous recombination in bacteria and replaced by the itTA cDNA. The construct was then
injected in the pronuclei of fertilized eggs. itTA=improved tetracycline transactivator; AMP=ampicillin resistance gene; PA=polyadenylation site;
FRT=Flippase recognition target. Below, a scheme representing the LacZtetOhGR construct (B) Lac Z expression revealed by Xgal staining (blue) in
islets and in exocrine tissue in Pdx-itTA/LacZtetOhGR mice. (C) Magnified view of the boxed area of B with arrows pointing at blue cells in the
exocrine tissue. (D) Absence of blue staining in control mice carrying only the LacZtetOhGR transgene. Two islets are outlined. Scale bar=50 mm.
doi:10.1371/journal.pone.0030210.g001
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inducible itTA, beta-galactosidase expression was assayed in adult
Pdx1-itTA/LacZtetOhGR mice. We observed a marked expres-
sion of beta-galactosidase gene as revealed by Xgal staining in
pancreatic islets (Fig. 1B) as well as a sparse staining in pancreatic
exocrine cells (Fig. 1C, arrows). No staining was observed in
control LacZtetOhGR mice (Fig. 1D) demonstrating that the
lacZ expression is dependent upon the presence of the itTA.
Analysis of other organs revealed itTA mediated expression of
beta-galactosidase in very sparse cells of the stomach, duodenum
and kidney (data not shown). This result is in agreement with
Pdx1 expression in few cells of the stomach and duodenum [15].
However, no expression of Pdx1 has been so far reported in the
kidney.
To define the nature of beta-galactosidase-expressing cells in the
adult pancreas, we performed immunofluorescence on pancreatic
sections from adult Pdx1-itTA/LacZtetOhGR mice (Fig. 2). We
observed blue staining reflecting the expression of the itTA in all
insulin-expressing cells (Fig. 2C and D) and in a fraction of
somatostatin-expressing cells (Fig. 2K and L). In contrast, no blue
staining was detected in the glucagon- (Fig. 2G and H) or PP-
(Fig. 2O and P) expressing cells. Yet, we observed few scattered
blue amylase-expressing cells (Fig. 2S and T). Pdx1 is expressed in
beta and delta cells and according to a former study also in acinar
Figure 2. The Pdx1-itTA activates lacZ expression in beta, delta and in acinar cells. (A) (E) (I) (M) and (Q) LacZ expression revealed by Xgal
staining (blue) on adult pancreatic sections from a Pdx1-itTA/LacZtetOhGR mouse. (B) Immunofluorescence for insulin (green), (C) merge of A and B
and (D) magnified view of inset in C. (F) Immunofluorescence for glucagon (green), (G) merge of E and F and (H) magnified view of inset in G. (J)
Immunofluorescence for somatostatin (green), (K) merge of I and J and (L) magnified view of inset in K. (N) Immunofluorescence for PP (green), (O)
merge of M and N and (P) magnified view of inset in O. (R) Immunofluorescence for amylase (green), (S) merge of Q and R and (T) magnified view of
inset in S. Scale bar=50 mm except for D, H, L, P and T where scale bar=10 mm.
doi:10.1371/journal.pone.0030210.g002
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expression of the endogenous Pdx1 gene.
Since Pdx1 is expressed early during pancreatic organogenesis,
we analyzed the expression of Pdx1-itTA in fetuses. As early as
E11.5, blue cells were detected both in the ventral and dorsal buds
(Fig. 3A). These buds are separated at E11.5 but fuse later during
pancreas development. At E13.5, all pancreatic cells are blue
(Fig. 3B) reflecting the fact that at this stage most of the pancreatic
cells are undifferentiated precursors. This staining was also
observed at E15.5 (Fig. 3C).
Generation and characterization of Ins1-itTA transgenic
mice
The Insulin1 BAC clone contained 110 kb of DNA sequence
upstream from the Insulin1 gene start codon and 87 kb of DNA
downstream of the polyadenylation signals sequence of the gene.
This BAC clone is devoid of other known or predicted genes
(Fig. 4A). The clone was modified by recombination in bacteria to
introduce the itTA gene into the BAC at a position that ensures
inactivation of the Insulin1 gene.
The excised fragments from both Pdx1 and Insulin1 modified
BACs were purified and injected into mouse C57BL/6J zygotes.
We obtained and established one transgenic line harboring the
Pdx1-itTA transgene and two other lines harboring the Insulin1-
itTA transgene. These transgenic mice were named Tg:BAC-Ins1-
itTA and will be referred in the manuscript as Ins1-itTA mice.
To characterize the Ins1-itTA expression, we used the same
strategy as for the Pdx1-itTA and crossed the Ins1-itTA mice with
LacZtetOhGR mice. We first analyzed pancreata of mice
containing both Ins-itTA and LacZtetOhGR transgenes. Xgal
staining on pancreatic sections revealed a blue staining only in
islets (Fig. 4B). The control mice that contain only the
LacZtetOhGR transgene showed no blue staining on pancreatic
sections (Fig. 4C), demonstrating that the lacZ expression is
dependent upon the presence of the itTA. Analysis of other organs
demonstrated no blue staining in the other organs analyzed
(stomach, kidney, duodenum). To characterize the blue cells in the
adult pancreas, we performed immunofluorescence on adult
pancreatic sections of Ins1-itTA/LacZtetOhGR mice. We found
that blue cells were positive for insulin (Fig. 5C and D) and all
insulin-expressing cells were blue. In contrast, no blue cells were
found in the glucagon- (Fig. 5G and H), somatostatin- (Fig. 5K and
L), PP- (Fig. 5O and P) or amylase- (Fig. 5S and T) expressing
cells. Thus, the expression of the Ins1-itTA is restricted to beta
cells and recapitulates the expression of the endogenous Insulin1
gene. The expression of the Insulin1 gene starts during pancreatic
organogenesis. Therefore, we analyzed the expression of Ins1-itTA
in fetuses. At E11.5, no blue cells were detected in pancreatic buds
from Ins1-itTA/LacZtetOhGR fetuses (data not shown). At E13.5,
few scattered blue cells were found (Fig. 6A) both in the dorsal
(Fig. 6B) and ventral (Fig. 6C) buds. At E15.5, clusters of blue cells
were observed throughout the whole pancreas (Fig. 6D and E).
Control of gene expression by doxycycline
The tetracycline system can be controlled using doxycycline
(Dox), an analog of tetracycline. First, we tested if lacZ expression
in Pdx1-itTA/LacZtetOhGR mice could be silenced by giving
Dox in the drinking water to adult mice. In the absence of Dox
treatment, blue staining was observed in the pancreata of adult
Pdx1-itTA/LacZtetOhGR mice (Fig. 7A). After 4 weeks of Dox
treatment, no blue cells could be observed in the pancreatic
sections from Pdx1-itTA/LacZtetOhGR mice (Fig. 7B), demon-
strating that Dox could silence the lacZ expression.
We then tested if lacZ expression could be re-induced in the
adult after silencing early in life. To do so, pregnant females
carrying Pdx1-itTA/LacZtetOhGR and control LacZtetOhGR
fetuses were given Dox in the drinking water from E0 (identified
by a vaginal plug). Dox treatment was maintained until weaning.
At weaning, we analyzed pancreata from Pdx1-itTA/LacZte-
tOhGR mice and did not observed any blue cells (Fig. 7C),
demonstrating that Dox treatment was efficient to silence lacZ
expression. After weaning, Dox treatment was stopped and mice
were analyzed 8 weeks thereafter. We observed blue cells in
pancreata from Pdx1-itTA/LacZtetOhGR mice (Fig. 7D) dem-
onstrating that lacZ expression could be induced after having been
silenced from E0. Interestingly, we found blue cells only in islet
cells and not in exocrine cells in mice that were treated with Dox
from E0 to weaning, in contrast to Pdx1-itTA/LacZtetOhGR
mice that never received Dox and presented blue staining in acinar
cells (Fig. 1C). This suggests that long-term transgene expression in
acini depends on its transient activity during fetal pancreas
development.
In separate experiments, similar controls of LacZ expression by
Dox were obtained with Ins1-itTA/LacZtetOhGR mice (data not
shown).
Overexpression of the Glucocorticoid Receptor (GR) in
pancreatic cells and its consequences on glucose
homeostasis and beta cells
After establishing that Pdx1-itTA and Ins1-itTA transgenic
mice express the itTA in distinct cell populations especially during
pancreatic development, we took advantage of these mice to better
define the role of the glucocorticoid signaling pathway in the
regulation of beta-cell mass and function. The double transgenic
mice that were used to define the itTA activity express both the
LacZ reporter gene and the humanized form of the Glucocorticoid
Receptor (GR) under the control of the TetO. GR overexpression
was confirmed by immunostaining for the GR on pancreatic
sections, we observed a weak staining for a control mouse
(LacZtetOhGR, Fig. 8A), and stronger stainings for a Pdx1-itTA/
Figure 3. The Pdx1-itTA is active early during fetal development in pancreatic precursors. (A) LacZ expression revealed by Xgal staining
in pancreatic buds at E11.5 and in the entire pancreas at E13.5 (B) and E15.5 (C) from Pdx-itTA/LacZtetOhGR fetuses. d=dorsal; v=ventral;
st=stomach.
doi:10.1371/journal.pone.0030210.g003
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(Fig. 8C) mice, confirming GR overexpression.
In Pdx1-itTA/LacZtetOhGR, GR overexpression was achieved
in cells that express the itTA, more precisely the early progenitors
in the fetal pancreas and beta cells. GR overexpression led to a
decreased beta-cell fraction measured in adult Pdx1-itTA/
LacZtetOhGR mice (Fig. 8D) with a trend for a decreased beta-
cell mass (Fig. 8E) but no alteration of glucose tolerance as assessed
by an intraperitoneal Glucose Tolerance Test (ipGTT, Fig. 8F and
G) when compared to control LacZtetOhGR mice. Insulin
secretion measured during the ipGTT 15 minutes after glucose
load was comparable in the two groups (0.7460.17 ng/ml in
Pdx1-itTA/LacZtetOhGR vs 0.6360.16 ng/ml in LacZtetOhGR
mice).
In the second transgenic mouse model, Ins1-itTA mice, we
show that GR overexpression in beta cells had no effect on beta-
cell fraction (Fig. 8H) or mass (Fig. 8I). However, GR
overexpression in beta cells alters their function with higher blood
glucose levels during an ipGTT (Fig. 8J and K) and decreased
insulin release (0.6060.18 ng/ml in Ins1-itTA/LacZtetOhGR vs
0.9560.37 ng/ml in LacZtetOhGR mice, p,0.05) 15 minutes
after glucose injection. Our data thus demonstrate that GR
overexpression in pancreatic cells regulates beta-cell mass or
function depending on the temporal window of overexpression.
Discussion
The use of transgenic mice is helpful to understand general
biological processes and the roles of specific genes with genetic
modifications such as gene deletion, gene overexpression and
lineage tracing through cell labeling. More specifically, great
knowledge about genes that regulate pancreatic development and
beta-cell function has been gathered thanks to the use of genetic
manipulation in mice (for review see [16]).
Here we present novel mice allowing conditional gene
overexpression in specific pancreatic cells using genetically
modified BACs. The first mouse model allows for gene
overexpression early in development in pancreatic precursors,
under the control of Pdx1 regulatory sequences. The second
model allows for gene overexpression in beta cells only, using the
Insulin1 gene regulatory sequences.
By crossing Pdx1-itTA mice with LacZtetOhGR mice carrying
a bidirectional TetO promoter that governs both LacZ reporter
gene and the human GR expression, we show that itTA is
Figure 4. Generation and characterization of mice expressing the itTA under the control of Insulin1 regulatory elements. (A) Bacterial
Artificial Chromosomes (BAC) containing around 200 kb of the genomic region of Insulin1 was obtained from BAC libraries developed by the CHORI,
Oakland USA. The coding region of the gene was removed by homologous recombination in bacteria and replaced by the itTA cDNA. The construct
was then injected in the pronuclei of fertilized eggs. itTA=humanized tetracycline transactivator; AMP=ampicillin resistance gene;
PA=polyadenylation site; FRT=Flippase recognition target. (B) Lac Z expression revealed by Xgal staining (blue) in islets in Ins1-itTA/LacZtetOhGR
mice. (C) Absence of blue staining in control mice carrying only the LacZtetOhGR transgene. Two islets are outlined. Scale bar=50 mm.
doi:10.1371/journal.pone.0030210.g004
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ment and at adult age, in beta cells, delta cells and some acinar
cells. This expression pattern reproduces the endogenous expres-
sion of Pdx1 (18), except for its acinar expression. Hence, by
immunostaining, Pdx1 cannot be detected in acinar cells.
However, a previous study has shown that the Pdx1 promoter
was sufficient to drive expression of LacZ in acinar cells [15]. It is
therefore possible that Pdx1 is actually expressed in acinar cells, at
a level below the detection threshold of immunohistochemistry but
sufficient to produce enough itTA and activate the TetO element.
In agreement with this possibility, Xgal staining was indeed
weaker in acinar cells than in islet cells.
In the Ins1-itTA mouse line, we show that the itTA activity is
found later than in the Pdx1-itTA mouse line during pancreatic
development and only in beta cells. In contrast to Pdx1-itTA mice,
no expression of the itTA was detected in acinar cells. This mouse
line clearly recapitulates the endogenous expression of the Insulin1
gene.
One of the major advantages of these novel mouse lines is that
they are versatile. Once generated, mice expressing the itTA in
specific cells can be used to overexpress genes of interest by
crossing them with mice that bear a tetracycline-regulated
transgene. In the present study, we give an example of this
versatility by crossing our mice with mice with a tetracycline-
Figure 5. The Ins1-itTA transgene activates lacZ expression only in beta cells. (A), (E), (I), (M) and (Q) LacZ expression revealed by Xgal
staining (blue) on adult pancreatic sections from a Ins1-itTA/LacZtetOhGR mouse. (B) Immunofluorescence for insulin (green), (C) merge of A and B
and (D) magnified view of inset in C. (F) Immunofluorescence for glucagon (green), (G) merge of E and F and (H) magnified view of inset in G. (J)
Immunofluorescence for somatostatin (green), (K) merge of I and J and (L) magnified view of inset in K. (N) Immunofluorescence for PP (green), (O)
merge of M and N and P magnified view of inset in O. (R) Immunofluorescence for amylase (green), (S) merge of Q and R and (T) magnified view of
inset in S. Scale bar=50 mm except for D, H, L, P and T where scale bar=10 mm.
doi:10.1371/journal.pone.0030210.g005
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We chose to overexpress the GR since our previous results have
defined the glucocorticoids (GCs) as potent negative regulators of
beta-cell development. Both in rats [4] and mice [5], we have
shown that excess GCs following food restriction during late fetal
development impair pancreatic beta-cell development, effects that
were most probably mediated through the GR [5]. Moreover, we
have shown that GR deletion specifically in beta cells (using
RipCre mice) had no effect on beta-cell mass while GR deletion in
pancreatic precursors (using PdxCre mice) led to a doubled beta-
cell mass [3]. These results defined GCs as major inhibitors of
beta-cell development. In order to further define the role of the
GR on beta-cell mass and function, we overexpressed the GR in
pancreatic precursors (Pdx1-itTA mouse line) or in developing and
mature beta cells (Ins1-itTA mouse line). In Pdx1-itTa/LacZte-
tOhGR mice, we observed a decreased beta-cell mass but no effect
on glucose tolerance and insulin secretion. This suggests that
forced GCs signaling in pancreatic precursors influenced beta-cell
differentiation and mass. On the other hand, forced GCs signaling
in beta cells led to a normal beta-cell mass but impaired insulin
secretion and glucose tolerance. Our present results indicate that
increasing GCs signaling pathway in precursor cells leads to a
long-term change in the beta-cell fraction, reinforcing the idea that
a direct action of GCs in precursor cells may be the cause of the
long-term changes observed after prenatal stress induced by
maternal food restriction. The results obtained by overexpressing
GR in mature beta cells suggest that later, GCs signaling does
control beta-cell function but does not affect the beta-cell mass
anymore. This demonstrates that GCs action on beta-cell mass is
restricted to a window-frame, between the appearance of
precursors and beta-cell differentiation. The overexpression in
differentiated beta cells is in agreement with previous results
obtained on transgenic mice overexpressing the GR in pancreatic
beta cells and showing glucose intolerance [17].
The second advantage of the Tetracycline system we used here
relies on the fact that itTA activity can be controlled by the
administration of a tetracycline analog, Doxycycline (Dox). Dox
treatment inhibits itTA activity and thus extinguishes the
overexpression of the gene controlled by the Tetracyline-
dependent promoter. Therefore, gene overexpression can be
silenced or induced during specific time frames. This is of utmost
importance since many genes play roles both during fetal
development and in mature cells. For example, Pdx1 is a
transcription factor that controls pancreas development since its
deletion leads to pancreatic agenesis [18]. However, it is also
expressed in mature beta cells where it controls the expression of
many genes such as Insulin or the glucose transporter Glut2 [19]. A
good example of separate roles of genes during development or in
mature cells originates from our studies on the GR. Conditional
GR gene deletion in pancreatic precursors led to a doubled beta-
cell mass while its inactivation in mature beta cells did not result in
any phenotype, revealing separate roles of the GR gene in
precursor or mature beta cells. Since we provide evidence that the
itTA activity and the expression of the gene of interest that it
controls can be conveniently controlled by Dox administration to
Figure 6. The Ins1-itTA is active in cells expressing insulin during fetal life. (A) LacZ expression in pancreatic buds at E13.5 in the dorsal (B)
and ventral (C) part of the pancreas from Ins1-itTA/LacZtetOhGR fetuses. (D) LacZ expression is found at E15.5 in scattered cells. (E) A view of the
dissected pancreas at E15.5.
doi:10.1371/journal.pone.0030210.g006
Figure 7. The expression of LacZ can be extinguished or
induced in adult Pdx1-itTA/LacZtetOhGR mice. (A) Xgal staining
on a pancreatic section of an adult Pdx1-itTA/LacZtetOhGR mouse
without Dox treatment. (B) Absence of Xgal staining after 8 weeks of
Dox administration (1 mg/ml) in the drinking water of an adult Pdx1-
itTA/LacZtetOhGR animal. An islet is outlined. (C) Absence of Xgal
staining in a 28 days-old Pdx1-itTA/LacZtetOhGR mouse treated with
Dox (0.1 mg/ml) from E0. An islet is outlined. (D) Eight weeks after Dox
removal, Xgal staining is observed on a pancreatic section from a Pdx1-
itTA/LacZtetOhGR mouse. Note that in contrast with A, Xgal staining is
observed in islet cells and not in acinar cells. Scale bar=50 mm.
doi:10.1371/journal.pone.0030210.g007
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specific time frames and either in precursors or beta cells will
surely reveal helpful in understanding how specific genes control
beta-cell development and/or function.
One caveat of transgenic mice is the use of minimal promoters
that may not reproduce the endogenous expression. For example,
the rat insulin promoter (RIP) drives Cre expression both in beta
cells but also in discrete brain areas [20]. More recently, thorough
examination of Cre expression under the control of Pdx1 or Insulin
promoters has been achieved and revealed that both promoters
drive the expression of Cre in brain areas [21]. The transgenes
used here were constructed using BAC that contains around
200 kb of the genomic regions of Pdx1 or Insulin1 genes. Therefore,
one can assume that such large regions contain most of the
regulatory elements controlling these genes.
In conclusion, we present elegant novel mouse models that
allow inducible overexpression of transgenes in selected pancreatic
cell populations expressing either Pdx1 or Insulin1 regulatory
elements. We demonstrated the versatility of these models by
overexpressing the GR and revealed a dichotomy of increased
GR-mediated GC signaling in the pancreas. Early action on
precursors later affects beta-cell mass whereas action in mature
beta cells affects function. Thus, the use of the new itTA mice
presented here will help understand precise roles of genes in
pancreas development and beta-cell biology.
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Figure 8. Consequences of GR overexpression on beta-cell mass and glucose homeostasis in Pdx1-itTA/LacZtetOhGR or Ins1-itTA/
LacZtetOhGR mice. (A) Immunohistochemistry for the glucocorticoid receptor (GR, brown nuclear staining) on pancreatic sections from a control
LacZtetOhGR, (B) a Pdx1-itTA/LacZtetOhGR mouse and (C) a Ins1-itTA/LacZtetOhGR mouse. (D) Beta-cell fraction, (E) beta-cell mass, (F) blood glucose
during an intra-peritoneal glucose tolerance test and (G) corresponding Area Under the Curve (AUC) in adult Pdx1-itTA/LacZtetOhGR mice. (H) Beta-
cell fraction, (I) beta-cell mass, (J) blood glucose during an intra-peritoneal glucose tolerance test and (K) corresponding Area Under the Curve (AUC)
in adult Ins1-itTA/LacZtetOhGR mice. Results are expressed as means 6 SD for n=3–5 animals per group. * p,0.05 when comparing double
transgenic mice (Pdx1-itTA/LacZtetOhGR or Ins1-itTA/LacZtetOhGR) to control (LacZtetOhGR) mice using a Mann-Whitney non parametric test. Scale
bar=100 mm.
doi:10.1371/journal.pone.0030210.g008
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